An Initiative to Improve Detection of Depression in Primary Care

An Initiative to Improve Detection of Depression in Primary Care

Depression is one of the mental disorders that has been a continuous health problem in the

population of the world. It causes considerable changes in individual lives and subsequently

creates an enormous cost to health systems. Despite effective treatment existing for it, under-

diagnosis or misdiagnosis of Depression remains a critical barrier to its effective management.

The project will, therefore, fill this gap by using standardized screening tools in the deployment

of early detection and rapid treatment for Depression within a primary healthcare setting.

This plan is important because it is targeted to drive Efficiency in healthcare and patient care

through accurate Diagnoses of the ailment, Depression. It recognizes that primary health care

It is estimated that 6.7 per cent of the population in the United States is affected by Major

Depressive Disorder (MDD), which equates to 15 million people. Only 25 per cent of cases of

Depression are diagnosed because of the intervention of traditional healthcare systems. The

global burden of Major Depressive Disorder (MDD) is exaggerated by under-diagnosis and late

identification, which leads to an inflated cost of healthcare and an increased association with

various chronic conditions. The gap between the extent of MDD and its identification poses a

public healthcare challenge. Indeed, researchers have documented that while instruments like

PHQ-9 can improve the detection rate of Depression, the irregularities in implementing this kind

of equipment in healthcare affect its overall effectiveness. This substantial gap in primary health

care systems shows that there is a need for intervention to address depression treatment

It is essential to point out that about 5000 patients with the mental issue at hand attend the

mentioned clinic per year. It is a primary healthcare infrastructure with a 2-person team of

primary care physicians and workers that include Registered Nurses, Physician's assistants as

well and Medical Assistants to the patient. Services provided are annual physical examinations,

cases of simple ailments, and terminal diseases like hypertension and diabetes. Essentially, no

matter the variety of care services made available, it is possible to fail to notice common

depression assessments at regular patient check-ups. Kilkenny (2018) outlined that the guidelines

at the national level indicate that this kind of Depression screening for adult patients should be

integrated into the operations of primary health care. These standards recommend employing

properly validated shortlisting tools such as the Patient Health Questionnaire-9 (PHQ-9) to rule

In depressive signs quickly. Hence, regarding the present protocols for depression screening and

This healthcare deficiency also calls for early detection and treatment to be made possible by the

systematic screening for Depression, hence the need for this quality improvement project. The

local challenge can be an example of a national issue; 97% of primary healthcare practitioners

detection and provide a roadmap for a comprehensive transformation of the healthcare systems

across the country to improve the quality and patient satisfaction to address Depression.

Available Knowledge

A quantum leap in properly identifying depression risk among the populace was the introduction

of resources such as the PHQ-9 screening tool for Depression. However, even with such a

resource, implementation into mainstream health practice is uncommon. Salinas, Gilder, and

Gray (2023) conducted a study on the use and absence of screening tools in actual clinical

practice. This study is among those that find that a systematically organized screening can add to

patients' experiences, as well as enhance the detection of Depression.

The American Psychiatric Association and other national health bodies believe that screening for

Depression regularly will lead to earlier diagnosis and, finally, improved treatment outcomes.

This project has been initiated to implement such recommended strategies in the local healthcare

structure to bridge the existing gap in well-organized applications for screening purposes.

The evidence Salinas et al. (2023) provided supports the feasibility and effectiveness of

implementing structured screening processes. If the screening interventions are well

implemented, they would significantly reduce the proportion of undetected Depression among

influence the state of population health more positively. The model proposed by the project for

translating this factual screening strategy into routine healthcare visits is very fundamental in

regularizing and systemizing practice in relation to the screening of Depression at primary

healthcare facilities (Holland, 2022).

existing literature treating the theme related to the critical value and importance of integrating

The key to using the recommended strategy consists of consistently integrating depression

screening procedures and using tested tools, including the Patient Health Questionnaire-9 (PHQ-

9), in primary healthcare settings. This is a convenient way to quickly react to depressive signs

and provide the necessary treatment, which significantly raises the average level of healthcare

screening tool that helps to replace part of the ineffective basic healthcare with a more effective

and efficient mental healthcare model. This strategy addresses the fundamental issue of the

interconnection between psychological and physical health by using therapy, screening

procedures, and support. This study aims to employ this approach towards helping healthcare

providers enhance the patients' mental health, hence guaranteeing the temporary benefits of the

wellness approach as well as positively affecting the well-being of the population in the long run.

As brought out by the research and advice made in the earlier reviewed studies, this extensive

approach demonstrates that the project contains the prospective to make a significantly large,

positive impact on population wellness and its distinct capacity to fill the contemporary lapse in

depression cures.

Depression is a serious worldwide condition that combines several health aspects and contributes

largely to the burden of disability. Accurate detection and timely intervention in the healthcare

The following SMART target has been set for the project in relation to addressing the lack of

depression screens in a primary care clinic. Over a 2- to 3-month period, the providers will work

in the PHQ-2 and PHQ-9 depression screening tools into the routine patient assessment that

occurs with each visit to the clinic, screening for Depression in at least a minimum of 75% of all

adult patient visits, thereby achieving an adequate rate of coverage for depression screening as a

baseline measure for future improvement—the aim of improving mental healthcare. The

objective is time-bound (by the short term of project implementation), can be measurable by an

increase in the screening coverage, and is possible with the training of the staff.

Project Question (Utilizing the PICOT Framework)

For adult patients presenting to a primary care clinic, is the rate of identifying Depression

increased with standardized screening tools introduced and taught than for patients who receive

no routine depression screening over 2-3 months?

other mental and physical problems that interfere with functioning at work, in the family, and

different aspects of living (American Psychiatric Association, 2024).

Primary Care Clinic: According to The Institute of Medicine (1996), a primary care clinic is a

health care setting that provides easy accessibility of any kind and a full treatment scope for a

wide range of conditions prevalent in the population.

Standardized Screening Tool: This screening instrument has been standardized based on

extensive research to quantify and identify signs of specific diseases in populations at any given

time. The instrument is standardized in terms of its administration, recording, and scoring; thus,

results are identical no matter who the actual administrator is. The Patient Health Questionnaire

(PHQ-9) is a standardized screening instrument utilized in the benefits of clinical research. It is

It deals with the ratio of those in the target population who have already gone under the

depression screening and through the application that incorporates several tools for the purpose,

among them the PHQ-9. Such screening coverage rates being high, the better it is for it assures

early diagnosis and treatment of depression conditions, and it does massively improve outcomes.

Those screening interventions register effectively, focusing on screening the target population as

much as it is possible, a significant proportion of those in the target population—more

specifically, those exposed to the most considerable risks to ensure all those in need of care are

identified and receive proper intervention according to USPSTF, (2021).

The application of the PHQ-2 and PHQ-9 in the identification of Depression would mean steps

in doing fine quality enhancement in virtually all aspects that pertain to care provision as far as

During this project implementation, the clinic can significantly ensure that the diagnosis of

Literature Search Strategies

application of PHQ-2 and PHQ-9 in a hospital environment were included in the study.

Studies conducted outside of medical centers and documents that did not undergo peer review

were deliberately avoided. The search yielded 878 articles, which were narrowed down further to

six after search-related trimming, title, abstract review, and full-text review to select literature

sources relevant to Depression screening with the use of PHQ screening tools.

Literature Review

The reviewed literature spanned a variety of studies, all of which have maintained that the PHQ-

2 and PHQ-9 screening instruments for Depression are quite instrumental (citations) in selected

settings for healthcare reasons. Clinical efficacy, understanding, and accuracy of tools made it

universal applicability of the PHQ-9 test, state that Costantini et al. (2021) backed it and

indicated the potential of it becoming a universal tool in the depression screening process. Bryan

(2023) also adds that specifically, the PHQ-9 is evidenced to be used to help identify patients

who are at risk of committing suicide, hence putting it out there that the screening tool is useful

in examining possible cases of Depression in the medical setting.

probably benefit the global reduction in Depression, especially among pregnant or postpartum

women, who could see other successful cognitive behavioural therapies. It presented a wide

potential for the PHQ-2 and PHQ-9 tools to come up with better treatment and identification for

tools in healthcare settings in determining the onset of Depression. Much consensus underlines

the integral role the screening tools play in earlier diagnoses and treatment. All these strategies of

the screening tool have great practical use. Still, there are several challenges to be managed: time

A study by Bryan (2023) emphasized the need for suicide risk management in collaboration with

establishing the effectiveness of linking suicide risk analysis to depression screening, which is

very instrumental in better detection and management of at-risk individuals. Linking these two

tools brings about several advantages: The PHQ-2 and PHQ-9 are previously validated effective

tools. In this study, some challenges involving the time consumed by its application and also the

necessity of adequate training for healthcare professionals were considered. More studies are still

needed to follow up on the long-term outcomes for patients following a screening. Such

techniques are very instrumental in enhancing earlier recognition and intervention, which later

Through some systemic approach in analysis and synthesis enabled by these appendices, clinical

guidelines could be drafted with respect to evidence for applying PHQ-2 and PHQ-9 screening